198 related articles for article (PubMed ID: 1894376)
1. Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.
Moayeri N; Collins CM; O'Hanley P
Infect Immun; 1991 Oct; 59(10):3778-86. PubMed ID: 1894376
[TBL] [Abstract][Full Text] [Related]
2. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
Pecha B; Low D; O'Hanley P
J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
[TBL] [Abstract][Full Text] [Related]
3. Protection against experimental Proteus mirabilis pyelonephritis in rats and significance of immunity.
Larsson P; Kaijser B; Olling S; Akerlund AS
Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):215-20. PubMed ID: 31056
[TBL] [Abstract][Full Text] [Related]
4. Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein.
Scavone P; Umpiérrez A; Rial A; Chabalgoity JA; Zunino P
Antonie Van Leeuwenhoek; 2014 Jun; 105(6):1139-48. PubMed ID: 24771125
[TBL] [Abstract][Full Text] [Related]
5. Effects of Taishan Pinus massoniana pollen polysaccharide on the subunit vaccine of Proteus mirabilis in birds.
Cui G; Zhong S; Yang S; Zuo X; Liang M; Sun J; Liu J; Zhu R
Int J Biol Macromol; 2013 May; 56():94-8. PubMed ID: 23403027
[TBL] [Abstract][Full Text] [Related]
6. Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.
Li X; Lockatell CV; Johnson DE; Lane MC; Warren JW; Mobley HL
Infect Immun; 2004 Jan; 72(1):66-75. PubMed ID: 14688082
[TBL] [Abstract][Full Text] [Related]
7. Nasal immunization with attenuated Salmonella Typhimurium expressing an MrpA-TetC fusion protein significantly reduces Proteus mirabilis colonization in the mouse urinary tract.
Scavone P; Umpiérrez A; Maskell DJ; Zunino P
J Med Microbiol; 2011 Jul; 60(Pt 7):899-904. PubMed ID: 21415205
[TBL] [Abstract][Full Text] [Related]
8. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.
O'Hanley P; Lalonde G; Ji G
Infect Immun; 1991 Mar; 59(3):1153-61. PubMed ID: 1671776
[TBL] [Abstract][Full Text] [Related]
9. Vaccination to Protect Against Proteus mirabilis Challenge Utilizing the Ascending Model of Urinary Tract Infection.
Smith SN; Himpsl SD; Mobley HLT
Methods Mol Biol; 2019; 2021():201-215. PubMed ID: 31309507
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice.
Scavone P; Miyoshi A; Rial A; Chabalgoity A; Langella P; Azevedo V; Zunino P
Microbes Infect; 2007 Jun; 9(7):821-8. PubMed ID: 17540603
[TBL] [Abstract][Full Text] [Related]
11. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
[TBL] [Abstract][Full Text] [Related]
12. Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice.
Udhayakumar V; Muthukkaruppan VR
Infect Immun; 1987 Mar; 55(3):816-21. PubMed ID: 3546142
[TBL] [Abstract][Full Text] [Related]
13. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2018 Apr; 117():348-355. PubMed ID: 29452195
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin M and immunoglobulin G responses in BALB/c mice to conjugated outer membrane extracts of four Salmonella serotypes.
Kudrna DA; Teresa GW; Arnzen JM; Beard KS
Infect Immun; 1985 Sep; 49(3):598-608. PubMed ID: 4030094
[TBL] [Abstract][Full Text] [Related]
15. [Protective properties of Proteus ribosomal vaccine].
Ovetchin PV; Tsyganenko AIa
Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):19-23. PubMed ID: 6367317
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.
Maeba S; Otake S; Namikoshi J; Shibata Y; Hayakawa M; Abiko Y; Yamamoto M
Vaccine; 2005 Mar; 23(19):2513-21. PubMed ID: 15752838
[TBL] [Abstract][Full Text] [Related]
17. Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice.
Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
Infect Immun; 2008 Jul; 76(7):2958-65. PubMed ID: 18426881
[TBL] [Abstract][Full Text] [Related]
18. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
[TBL] [Abstract][Full Text] [Related]
19. Humoral response in mice immunized with outer membrane proteins of Shigella flexneri.
Witkowska D; Czarny A; Mulczyk M
Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):499-504. PubMed ID: 3296993
[TBL] [Abstract][Full Text] [Related]
20. ECA-immunogenicity of Proteus mirabilis strains.
Duda KA; Duda KT; Beczała A; Kasperkiewicz K; Radziejewska-Lebrecht J; Skurnik M
Arch Immunol Ther Exp (Warsz); 2009; 57(2):147-51. PubMed ID: 19333729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
